Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy

Epilepsy Research

Volumn 91, Issue 2-3, 2010, Pages 273-282

  Malerba, Ambra ^a   Ciampa, Clotilde ^b   De Fazio, Salvatore ^c   Fattore, Cinzia ^d   Frassine, Benedetta ^e,f   La Neve, Angela ^g   Pellacani, Simona ^h   Specchio, Luigi Maria ⁱ   Tiberti, Alessandra ^f   Tinuper, Paolo ^j   Perucca, Emilio ^a,d  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^e CARLO POMA HOSPITAL   (Italy)

^f Spedali Civili   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITY OF FOGGIA   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

more..

Author keywords

Drug resistance; Drug utilization; Epilepsy; Pharmacoepidemiology

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIULCER AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; HYPNOTIC AGENT; LAMOTRIGINE; NEUROLEPTIC AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; THYROID HORMONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG UTILIZATION; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; IDIOPATHIC DISEASE; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MYOCLONUS EPILEPSY; PREDICTION; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; TERTIARY HEALTH CARE; TONIC CLONIC SEIZURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; PRESCRIPTIONS; REFERRAL AND CONSULTATION; YOUNG ADULT;

EID: 77957019275     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.08.002     Document Type: Article

References (54)

1. Abasolo-Osinaga E., Abecia-Inchaurregui L.C., Etxeandia-Ikobaltzeta I., Burgos-Alonso N., Garcia-del Pozo J. A pharmacoepidemiological study of antiepileptic drug consumption (1992-2004). Rev. Neurol. 2008, 46:449-453. (in Spanish).
2. Aylward R.L. Epilepsy: a review of reports, guidelines, recommendations and models for the provision of care for patients with epilepsy. Clin. Med. 2008, 8:433-438.
3. Alexandre V., Capovilla G., Fattore C., Franco V., Gambardella A., Guerrini R., La Briola F., Ladogana M., Rosati E., Specchio L.M., Striano S., Perucca E Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centres in Italy. Epilepsia 2010, 51:921-925. on behalf of the SOPHIE Study Group.
4. Banfi R., Borselli G., Marinai C., Borgheresi A., Cavalieri A. Epidemiological study of epilepsy by monitoring prescriptions of antiepileptic drugs. Pharm. World Sci. 1995, 17:138-140.
5. Beghi E., Monticelli M.L., Monza G., Sessa A., Zarrelli M. Antiepileptic drugs as 'tracers' of disease. A calculation of the prevalence of epilepsy through an analysis of drug consumption. The Group for the Study of Epilepsy in General Practice. Neuroepidemiology 1991, 10:33-41.
6. Beghi E., Gatti G., Tonini C., Ben-Menachem E., Chadwick D., Nikaronova M., Gromov S., Smith P.E.M., Specchio L.M., Perucca E. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomized, pragmatic, controlled trial. Epilepsy Res. 2003, 57:1-13. on behalf on the BASE Study Group.
7. Brodie M.J., Dichter M.A. Established antiepileptic drugs. Seizure 1997, 6:159-174.
8. Canevini M.P., De Sarro G., Galimberti C.A., Gatti G., Licchetta L., Malerba A., Muscas G., La Neve A., Striano P., Perucca E. Relationship between adverse effects of antiepileptic drugs and drug load in a large cohort of consecutive patients with drug refractory epilepsy. Epilepsia 2010, 51:797-804. on behalf of the SOPHIE Study Group.
9. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489-501.
10. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
11. Forsgren L. Prevalence of epilepsy in adults in Northern Sweden. Epilepsia 1992, 33:450-458.
12. French J.A., Kanner A.M., Bautista J., Abou-Khalil B., Browne T., Harden C.L., Theodore W.H., Bazil C., Stern J., Schachter S.C., Bergen D., Hirtz D., Montouris G.D., Nespeca M., Gidal B., Marks W.J., Turk W.R., Fischer J.H., Bourgeois B., Wilner A., Faught R.E., Sachdeo R.C., Beydoun A., Glauser T.A. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1252-1260.
13. French J.A., Kanner A.M., Bautista J., Abou-Khalil B., Browne T., Harden C.L., Theodore W.H., Bazil C., Stern J., Schachter S.C., Bergen D., Hirtz D., Montouris G.D., Nespeca M., Gidal B., Marks W.J., Turk W.R., Fischer J.H., Bourgeois B., Wilner A., Faught R.E., Sachdeo R.C., Beydoun A., Glauser T.A. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1261-1273.
14. Gazzola D.M., Balcer L.J., French J.A. Seizure-free outcomes in randomized add-on trials of the new antiepileptic drugs. Epilepsia 2007, 48:1303-1307.
15. Giuliani G., Terziani S., Senigaglia A.R., Luccioni G., Foschi N., Maffei C. Epilepsy in an Italian community as assessed by a survey for prescriptions of antiepileptic drugs: epidemiology and patterns of care. Acta Neurol. Scand. 1992, 85:23-31.
16. Glauser T., Ben-Menachem E., Bourgeois B., Cnaan A., Chadwick D., Guerreiro C., Kalviainen R., Mattson R., Perucca E., Tomson T. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006, 47:1094-1120.
17. Goodridge D.M., Shorvon S.D. Epileptic seizures in a population of 6000. II: Treatment and prognosis. Br. Med. J. 1983, 287:645-647.
18. Hart Y.M., Shorvon S.D. The nature of epilepsy in the general population. II. Medical care. Epilepsy Res. 1995, 21:51-58.
19. Hermann B., Seidenberg M., Jones J. The neurobehavioural comorbidities of epilepsy: can a natural history be developed?. Lancet Neurol. 2008, 7:151-160.
20. Hsieh L.P., Huang C.Y. Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database. Epilepsy Res. 2009, 84:21-27.
21. Kanner A.M. Depression in epilepsy: a complex relation with unexpected consequences. Curr. Opin. Neurol. 2008, 21:190-194.
22. Keränen, T., 1988. Epilepsy in adults. An epidemiological study in Eastern Finland. Thesis. Kuopio University (Finland), Department of Neurology.
23. Lammers M.W., Hekster Y.A., Keyser A., Meinardi H., Renier W.O., Herings R.M.C. Use of antiepileptic drugs in a community-dwelling Dutch population. Neurology 1996, 46:62-67.
24. Landmark C.J., Rytter E., Johannessen S.I. Clinical use of antiepileptic drugs at a referral centre for epilepsy. Seizure 2007, 16:356-364.
25. Landmark C.J., Larson P.G., Rytter E., Johannessen S.I. Antiepileptic drugs in epilepsy and other disorders - a population based study of prescriptions. Epilepsy Res. 2009, 87:31-39.
26. Larsson K., Eeg-Olofsson O. A population based study of epilepsy in children from a Swedish county. Eur. J. Pediatr. Neurol. 2006, 10:107-113.
27. Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W., Cramp C., Cockerell O.C., Cooper P.N., Doughty J., Eaton B., Gamble C., Goulding P.J., Howell S.J., Hughes A., Jackson M., Jacoby A., Kellett M., Lawson G.R., Leach J.P., Nicolaides P., Roberts R., Shackley P., Shen J., Smith D.F., Smith P.E., Smith C.T., Vanoli A., Williamson P.R. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007, 369:1016-1026. SANAD Study group.
28. McCluggae J.R., Ramsey H.C., Itwin W.G., Dowds M.F. Antiepileptic therapy in a general practice population in Northern Ireland. J. Royal Coll. Gen. Practit. 1984, 34:24-31.
29. Muir T.M., Bradley S.F., Wood G.D., Murray G.D., Brodie M.J. An audit of treated epilepsy in Glasgow. Seizure 1996, 5:41-46.
30. National Institute for Clinical Excellence, 2004. Newer drugs for epilepsy, Technology Appraisal 76, NICE, London.
31. Olafsson E., Hauser W.A. Prevalence of epilepsy in rural Iceland: a population-based study. Epilepsia 1999, 40:1529-1534.
32. Oun A., Haldre S., Magi M. Use of antiepileptic drugs in Estonia: an epidemiologic study of adult epilepsy. Eur. J. Neurol. 2006, 13:465-470.
33. Perucca E. Pharmacologic advantages of antiepileptic drug monotherapy. Epilepsia 1997, 38(Suppl. 5):6-8.
34. Perucca E. Pharmacoresistance in epilepsy. How should it be defined?. CNS Drugs 1998, 10:171-179.
35. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002, 16:695-714.
36. Perucca E. An introduction to antiepileptic drugs. Epilepsia 2005, 46(Suppl. 4):31-37.
37. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br. J. Clin. Pharmacol. 2006, 61:246-255.
38. Perucca E., Kwan P. Overtreatment in epilepsy: how it occurs and how it can be avoided. CNS Drugs 2005, 19:897-908.
39. Perucca E., French J., Bialer M. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol. 2007, 6:793-804.
40. Peytchev L., Marazova K. Epidemiological study of the frequency of prescribing antiepileptic drugs. Folia Medica (Plovdiv) 1992, 34:8-13.
41. Peytchev L., Atanasova I., Terzhvanov D. Antiepileptic drug utilization in out-patients - a prescribing pattern study. Int. J. Clin. Pharmacol. Ther. 1996, 34:444-445.
42. Prpic I., Vlahovic-Palcevski V., Skarpa-Prpic I., Palcevski G., Boban M. Analysis of antiepileptic drugs use at a university hospital in Croatia. Eur. J. Neurol. 2005, 12:483-485.
43. Reynolds E.H., Shorvon S.D. Monotherapy or polytherapy for epilepsy?. Epilepsia 1981, 22:1-10.
44. Roberts S.J., Feely M., Bateman D.N. Prescribing of anti-epileptic drugs in the northern and Yorkshire region: 1992-1995. Seizure 1998, 7:127-132.
45. Rochat P., Hallas J., Gaist D., Friis M.L. Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol. Scand. 2001, 104:6-11.
46. Rutgers M.J. Epilepsy in general practice: the Dutch situation. Epilepsia 1986, 27:734-738.
47. Savica R., Beghi E., Mazzaglia G., Innocenti F., Brignoli O., Cricelli C., Caputi A.P., Musolino R., Spina E., Trifirò G. Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005. Eur. J. Neurol. 2007, 14:1317-1321.
48. Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults. Guideline n. 70, April 2003 (updated October 2005), SIGN, Edinburgh.
49. Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsies in children and young people. Guideline n. 81, March 2005 (updated October 2005), SIGN, Edinburgh.
50. Shackleton D.P., Westendorp R.G., Kasteleijn-Nolst Trenité D.G., de Boer A., Herings R.M. Dispensing epilepsy medication: a method of determining the frequency of symptomatic individuals with seizures. J. Clin. Epidemiol. 1997, 50:1061-1068.
51. Stein M.A., Kanner A.M. Management of newly diagnosed epilepsy: a practical guide to monotherapy. Drugs 2009, 69:199-222.
52. Tsiropoulos B., Gichangi A., Andersen M., Bjerrun L., Gaist D., Hallas J. Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol. Scand. 2006, 113:405-411.
53. van de Vrie-Hoekstra N.W., de Vries T.W., van den Berg P.B., Brouwer O.F., de Jong-van den Berg L.T. Antiepileptic drug utilization in children from 1997-2005 - a study from the Netherlands. Eur. J. Clin. Pharmacol. 2008, 64:1013-1020.
54. World Health Organization, 2009. ETC/DDD Index. (accessed 27.05.09). http://www.whocc.no/atcddd/indexdatabase/index.php.